These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16401681)

  • 1. Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma.
    Izzo JG; Malhotra U; Wu TT; Ensor J; Luthra R; Lee JH; Swisher SG; Liao Z; Chao KS; Hittelman WN; Aggarwal BB; Ajani JA
    J Clin Oncol; 2006 Feb; 24(5):748-54. PubMed ID: 16401681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma.
    Izzo JG; Correa AM; Wu TT; Malhotra U; Chao CK; Luthra R; Ensor J; Dekovich A; Liao Z; Hittelman WN; Aggarwal BB; Ajani JA
    Mol Cancer Ther; 2006 Nov; 5(11):2844-50. PubMed ID: 17121931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation.
    Izzo JG; Wu X; Wu TT; Huang P; Lee JS; Liao Z; Lee JH; Bhutani MS; Hofstetter W; Maru D; Hung MC; Ajani JA
    Dis Esophagus; 2009; 22(2):127-32. PubMed ID: 19021681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression.
    Izzo JG; Malhotra U; Wu TT; Luthra R; Correa AM; Swisher SG; Hofstetter W; Chao KS; Hung MC; Ajani JA
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1200-5. PubMed ID: 17548685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction.
    Ajani JA; Walsh G; Komaki R; Morris J; Swisher SG; Putnam JB; Lynch PM; Wu TT; Smythe R; Vaporciyan A; Faust J; Cohen DS; Nivers R; Roth JA
    Cancer; 2004 Jun; 100(11):2347-54. PubMed ID: 15160337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
    Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
    Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.
    Rohatgi P; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh GL; Vaporciyan AA; Rice DC; Roth JA; Ajani JA
    Cancer; 2005 Dec; 104(11):2365-72. PubMed ID: 16245310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of nuclear factor-κB expression in esophageal squamous cell carcinoma: prognostic significance and sensitivity to treatment with 5-FU.
    Hatata T; Higaki K; Tatebe S; Shomori K; Ikeguchi M
    Dis Esophagus; 2012; 25(8):716-22. PubMed ID: 22292507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
    Buchholz TA; Garg AK; Chakravarti N; Aggarwal BB; Esteva FJ; Kuerer HM; Singletary SE; Hortobagyi GN; Pusztai L; Cristofanilli M; Sahin AA
    Clin Cancer Res; 2005 Dec; 11(23):8398-402. PubMed ID: 16322301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
    Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
    Ajani JA; Wang X; Izzo JG; Crane CH; Eng C; Skibber JM; Das P; Rashid A
    Dig Dis Sci; 2010 Apr; 55(4):1098-105. PubMed ID: 19399614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
    Liu X; Wang B; Ma X; Guo Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma.
    Hong D; Lunagomez S; Kim EE; Lee JH; Bresalier RS; Swisher SG; Wu TT; Morris J; Liao Z; Komaki R; Ajani JA
    Cancer; 2005 Oct; 104(8):1620-6. PubMed ID: 16118804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated nuclear factor-kappa B and cytokine profiles in the esophagus parallel tumor regression following neoadjuvant chemoradiotherapy.
    Abdel-Latif MM; O'Riordan JM; Ravi N; Kelleher D; Reynolds JV
    Dis Esophagus; 2005; 18(4):246-52. PubMed ID: 16128781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer.
    Lee BL; Lee HS; Jung J; Cho SJ; Chung HY; Kim WH; Jin YW; Kim CS; Nam SY
    Clin Cancer Res; 2005 Apr; 11(7):2518-25. PubMed ID: 15814628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.
    Ajani JA; Mansfield PF; Crane CH; Wu TT; Lunagomez S; Lynch PM; Janjan N; Feig B; Faust J; Yao JC; Nivers R; Morris J; Pisters PW
    J Clin Oncol; 2005 Feb; 23(6):1237-44. PubMed ID: 15718321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.